Alexander George, PhD

Alex joined Health Advances in 2017 and brings experience in strategy development, due diligence, detailed pipeline and market forecasting, and market assessment, with a focus on life science research tools, bioprocessing, and biopharma services.

Prior to joining Health Advances, Alex was a Business Development Fellow at Harvard University, Office of Technology Development, and a Research Technician at Weill Cornell Medical College.

Alex holds a PhD in Chemical Biology from Harvard University and a BA in Biochemistry from Swarthmore College.